SCHEMBL4873695

SCHEMBL4873695

CN1CCC(Sc2ccc(NS(=O)(=O)c3ccc(F)cc3)cc2)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.58
MAPK1 P28482 2/20 0.58
POLB P06746 2/20 0.51
MAPT P10636 2/20 0.50
KMT2A Q03164 3/20 0.49
MEN1 O00255 2/20 0.49
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
PKM P14618 2/20 0.46
HRH3 Q9Y5N1 1/20 0.46
HTT P42858 1/20 0.46
RECQL P46063 1/20 0.46
TP53 P04637 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HTR2A P28223 1/20 0.45
HTR2C P28335 1/20 0.45
HTR1F P30939 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4874458 0.89 ALDH1A1 (0.44) ALDH1A1MAPK1MAPTKMT2AMEN1
SCHEMBL4866321 0.89 ALDH1A1 (0.57) ALDH1A1MAPK1POLBMAPTKMT2A
SCHEMBL4876385 0.88 HTR6 (0.49) ALDH1A1MAPK1MAPTKMT2AMEN1
SCHEMBL4876689 0.88 CES1 (0.54) ALDH1A1POLBMAPTKMT2ACYP3A4
SCHEMBL4874044 0.86 ALDH1A1 (0.62) ALDH1A1MAPTKMT2AMEN1CYP3A4
SCHEMBL4876786 0.86 ALDH1A1 (0.56) ALDH1A1POLBMAPTKMT2AMEN1
SCHEMBL6617076 0.86 ALDH1A1 (0.60) ALDH1A1MAPK1MAPTKMT2AMEN1
SCHEMBL4876622 0.85 ALDH1A1 (0.60) ALDH1A1MAPK1POLBKMT2AMEN1
SCHEMBL4869725 0.84 HTR2A (0.51) ALDH1A1MAPK1MAPTTP53SMN1; SMN2
SCHEMBL4868720 0.82 MAPT (0.49) ALDH1A1MAPTKMT2AMEN1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7408067-B2 Aza-cyclic compounds as modulators of acetylcholine receptors MERCK + CO., INC. (US) 2008-08-05 US disclosed
US-20050070520-A1 Aza-cyclic compounds as modulators of acetylcholine receptors MERCK SHARP & DOHME CORP. 2005-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050070520-A1 Aza-cyclic compounds as modulators of acetylcholine receptors CHRNG, CHRNA4, CHRNB4 ALDH1A1 1088/4885MAPK1 3708/4885POLB 3514/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.